Nayzilam
(midazolam)UCB, Inc.
Usage: NAYZILAM is indicated for the acute treatment of intermittent, stereotypic seizure clusters or acute repetitive seizures in epilepsy patients aged 12 years and older, which are distinct from their usual seizure patterns.